Drug Negotiation Suits Reflect Lobbying Failures, HHS Says

By Jeff Overley · August 14, 2023, 10:25 PM EDT

A barrage of legal challenges to landmark legislation empowering Medicare to negotiate drug prices is little more than a failed lobbying campaign "masquerading as constitutional theory," the U.S. Department of Health...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

MERCK & CO., INC. v. BECERRA et al

Case Number

1:23-cv-01615

Court

District Of Columbia

Nature of Suit

Civil Rights: Other

Date Filed

June 06, 2023

Case Title

Dayton Area Chamber of Commerce et al v. Becerra et al

Case Number

3:23-cv-00156

Court

Ohio Southern

Nature of Suit

Constitutional - State Statute

Date Filed

June 09, 2023

Case Title

BRISTOL MYERS SQUIBB COMPANY v. BECERRA et al

Case Number

3:23-cv-03335

Court

New Jersey

Nature of Suit

Civil Rights: Other

Date Filed

June 16, 2023

Case Title

National Infusion Center Association et al v. Xavier Becerra, et al

Case Number

1:23-cv-00707

Court

Texas Western

Nature of Suit

Civil Rights: Other

Date Filed

June 21, 2023

Case Title

Astellas Pharma US, Inc. v. Department of Health and Human Services et al

Case Number

1:23-cv-04578

Court

Illinois Northern

Nature of Suit

440(Civil Rights: Other)

Date Filed

July 14, 2023

Case Title

JANSSEN PHARMACEUTICALS, INC. v. BECERRA et al

Case Number

3:23-cv-03818

Court

New Jersey

Nature of Suit

Civil Rights: Other

Date Filed

July 18, 2023

Recent Articles By Jeff